|
Martek Biosciences Corporation - Company Profile Snapshot
| Company Profile: |
Martek Biosciences Corporation |
| Ticker: |
MATK |
| Exchanges: |
NAS |
| 2008 Sales: |
352,360,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Diversified Drugs, Cosmetics, & Health Care |
| Country: |
UNITED STATES |
| Employees: |
569 |
Business Description
Martek Biosciences Corporation. The Group's principal activity is to develop, manufacture and sell naturally produced products derived from microalgae, fungi and other microbes. The products and services include specialty, nutritional oils for infant formula, nutritional supplements and food ingredients to promote mental and cardiovascular health. The Group also develops new fluorescent detection products from microalgae that connect fluorescent algal proteins to antibodies. The trademarks of the Group include Neuromins (r), DHA Gold (r), DHASCO (r) and ARASCO (r). The Group operates in the United States, Europe and China.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
